- Review the basic principles PCSK9 activity
- Review the clinical PCSK9 modulation in the lipid metabolism
- Review the potential for PCSK9 modulation as a potential drug target for therapy
Dr. Verma currently holds the Canada Research Chair in Atherosclerosis and oversees or collaborates on multiple ongoing local and national research projects in the basic, translational and clinical sciences. These diverse studies all pivot around the central theme of vascular biology, endothelial dysfunction, inflammation, atherosclerosis and cardiac function, several of which bridge multiple disciplines (eg. nephrology to vascular biology, cardiac function to cancer) and/or focus on health issues with cross-cultural implications and applications.
Before we begin, please complete a very brief pre-test...